GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Price-to-Free-Cash-Flow

3SBio, (FRA:YFK) Price-to-Free-Cash-Flow : 3.90 (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is 3SBio, Price-to-Free-Cash-Flow?

As of today (2024-05-16), 3SBio,'s share price is €12.55. 3SBio,'s Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was €3.21. Hence, 3SBio,'s Price-to-Free-Cash-Flow Ratio for today is 3.90.

The historical rank and industry rank for 3SBio,'s Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:YFK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 31.15   Med: 43.16   Max: 58.29
Current: 58.21

During the past 13 years, 3SBio,'s highest Price-to-Free-Cash-Flow Ratio was 58.29. The lowest was 31.15. And the median was 43.16.

FRA:YFK's Price-to-Free-Cash-Flow is not ranked
in the Biotechnology industry.
Industry Median: 32.39 vs FRA:YFK: 58.21

3SBio,'s Free Cash Flow per Share for the six months ended in Dec. 2016 was €1.12. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €3.21.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of 3SBio, was 25.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -38.90% per year.

During the past 13 years, 3SBio,'s highest 3-Year average Free Cash Flow per Share Growth Rate was 75.80% per year. The lowest was 0.00% per year. And the median was 0.00% per year.


3SBio, Price-to-Free-Cash-Flow Historical Data

The historical data trend for 3SBio,'s Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Price-to-Free-Cash-Flow Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.64 14.78 - 58.18 32.13

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 93.75 58.18 - 32.13

Competitive Comparison of 3SBio,'s Price-to-Free-Cash-Flow

For the Biotechnology subindustry, 3SBio,'s Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Price-to-Free-Cash-Flow falls into.



3SBio, Price-to-Free-Cash-Flow Calculation

3SBio,'s Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12.55/3.214
=3.90

3SBio,'s Share Price of today is €12.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 3SBio,'s Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was €3.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

3SBio,  (FRA:YFK) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


3SBio, Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines